Drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction: plain language summary of the EMPEROR-Preserved study

Future Cardiology, Ahead of Print.
Source: Future Cardiology - Category: Cardiology Authors: Source Type: research